Supporting evidence for an active treatment program for advanced salivary gland carcinomas

Research output: Contribution to journalArticle

Abstract

The role of systemic chemotherapy in the treatment of salivary gland tumors remains unknown. Because of the infrequent occurrence of these tumors, only a few clinical trials with chemotherapy have been reported in the literature. The current trial presents preliminary results with the combination of cyclophosphamide, doxorubicin, and cisplatin. These results are viewed in terms of other recently reported data obtained with the same combination. The collected data strongly suggest that salivary gland tumors may be very responsive to chemotherapy.

Original languageEnglish (US)
Pages (from-to)319-321
Number of pages3
JournalCancer treatment reports
Volume69
Issue number3
StatePublished - Jan 1 1985
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Supporting evidence for an active treatment program for advanced salivary gland carcinomas'. Together they form a unique fingerprint.

  • Cite this